Aurore Morel

Psoriasis during angiotensin receptor blocker exposure: an underestimated adverse drug reaction

Brahim Azzouz, Malak Abou Taam, Aurore Morel et al. · Expert Opinion on Drug Safety · 2018 · 12 citations

Pharmacy, Internal Medicine, Pharmacotherapy +14

Psoriasis risk after beta‐blocker exposure: Description of a pharmacovigilance signal

Brahim Azzouz, Apolline De Guizelin, Aude Lambert et al. · British Journal of Clinical Pharmacology · 2022 · 11 citations · Full text

Pharmacy, Pharmacology, Pharmacotherapy +14

Bisphosphonate‐related osteonecrosis of the jaw: data from the French national pharmacovigilance database

Paul de Boissieu, Louise Gaboriau, Aurore Morel et al. · Fundamental and Clinical Pharmacology · 2016 · 10 citations

Dentistry, Maxillofacial Surgery, Oral Surgery +13

Methylphenidate and stuttering

Thierry Trenque, Gwladys Claustre, Emmanuelle Herlem et al. · British Journal of Clinical Pharmacology · 2019 · 10 citations · Full text

Pharmacy, Pharmacology, Pharmacotherapy +15

Drug induced stuttering: pharmacovigilance data

Thierry Trenque, Aurore Morel, Agathe Trenque et al. · Expert Opinion on Drug Safety · 2020 · 10 citations

Pharmacy, Pharmacology, Pharmacotherapy +13